Company
CanadaChongqing Taihao Pharmaceutical Co., Ltd., a division of Polymed Therapeutics, Inc., Jiulongpo District, Canada – FDA Inspections
Inspection records and compliance data for Chongqing Taihao Pharmaceutical Co., Ltd., a division of Polymed Therapeutics, Inc. in Jiulongpo District, Chongqing. Access full analysis and detailed observations.
Company Profile
This profile covers Chongqing Taihao Pharmaceutical Co., Ltd., a division of Polymed Therapeutics, Inc. based in Jiulongpo District, Chongqing, Canada.
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- Health Canada · 1 inspection · last May 7, 2018
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Southwest Synthetic Pharmaceutical Co. Ltd.
Diagnostic Imaging, Capital District Health Authority
Pharmasol Ltd.
Akorn AG
Strides Pharma Global Pte Limited
AP Martin Pharmaceutical Supplies Ltd
LAT GmbH Dr. Tittel, Institut fur Pharma-Analytik
Capua Bioservices S.P.A.
Glaxo SmithKline Biologicals
Occy Laboratoire Inc.
Company Information
Name
Chongqing Taihao Pharmaceutical Co., Ltd., a division of Polymed Therapeutics, Inc.
Address
No.105, Chuangye Road, Erlang, Jiulongpo District, Chongqing 400 039, Canada
Country
Canada
ID: 50df82a0-4780-446a-ba28-d26cfdd15d66